Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$45.39 USD
-0.43 (-0.94%)
Updated May 16, 2024 04:00 PM ET
After-Market: $45.37 -0.02 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.74 | -0.72% |
Earnings Summary
For their last quarter, Halozyme Therapeutics (HALO) reported earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.69 per share. This reflects a positive earnings surprise of 14.49%. Look out for HALO's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.74 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for HALO
Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
HALO: What are Zacks experts saying now?
Zacks Private Portfolio Services